• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

房颤触发因素对非阵发性房颤第二次导管消融长期结局的影响

Impact of Atrial Fibrillation Triggers on Long-Term Outcomes of a Second Catheter Ablation of Nonparoxysmal Atrial Fibrillation.

作者信息

Shinohara Masaya, Fujino Tadashi, Wada Ryo, Yao Shintaro, Yano Kensuke, Akitsu Katsuya, Koike Hideki, Kinoshita Toshio, Yuzawa Hitomi, Ikeda Takanori

机构信息

Division of Cardiovascular Medicine, Department of Internal Medicine, Toho University Faculty of Medicine Tokyo Japan.

Department of Cardiovascular Medicine, Toho University Graduate School of Medicine Tokyo Japan.

出版信息

Circ Rep. 2024 Feb 3;6(3):37-45. doi: 10.1253/circrep.CR-23-0069. eCollection 2024 Mar 8.

DOI:10.1253/circrep.CR-23-0069
PMID:38464985
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10920014/
Abstract

Catheter ablation (CA) of atrial fibrillation (AF) triggers, including non-pulmonary vein (PV) foci, contributes to improved procedural outcomes. However, the clinical significance of an AF trigger ablation during second CA procedures for nonparoxysmal AF is unknown. We enrolled 94 patients with nonparoxysmal AF undergoing a second CA. Intracardiac cardioversion during AF using high-dose isoproterenol was performed to determine the presence or absence of AF triggers. PV re-isolations were performed if PV potentials recurred, and if AF triggers appeared from any non-PV sites, additional ablation was added to those sites. We investigated the incidence of atrial arrhythmia recurrence (AAR) >3 months post-CA. Of the 94 enrolled patients, AF triggers were identified in 65 (69.1%), and of those with AF triggers, successful elimination of the triggers was achieved in 47 patients (72.3%). Multivariate analysis revealed that no observed AF triggers were a significant predictor of AAR (hazard ratio [HR] 1.97, 95% confidence interval [CI] 1.21-3.46, P=0.019). In a subanalysis of the patients with AF triggers, multivariate analysis showed that unsuccessful trigger ablation was significantly associated with AAR (HR 5.84, 95% CI 2.79-12.22, P<0.01). Having no observed AF triggers during a second CA session significantly increased the risk of AAR, as did unsuccessful CA of AF triggers.

摘要

导管消融(CA)房颤(AF)触发灶,包括非肺静脉(PV)灶,有助于改善手术效果。然而,在非阵发性AF的第二次CA手术中,AF触发灶消融的临床意义尚不清楚。我们纳入了94例接受第二次CA的非阵发性AF患者。在AF期间使用高剂量异丙肾上腺素进行心内转复,以确定是否存在AF触发灶。如果PV电位复发,则进行PV再次隔离,如果从任何非PV部位出现AF触发灶,则在这些部位增加额外消融。我们调查了CA后>3个月时房性心律失常复发(AAR)的发生率。在94例纳入患者中,65例(69.1%)发现有AF触发灶,在有AF触发灶的患者中,47例(72.3%)成功消除了触发灶。多因素分析显示,未观察到AF触发灶是AAR的显著预测因素(风险比[HR]1.97,95%置信区间[CI]1.21-3.46,P=0.019)。在对有AF触发灶患者的亚分析中,多因素分析表明触发灶消融失败与AAR显著相关(HR 5.84,95%CI 2.79-12.22,P<0.01)。在第二次CA手术期间未观察到AF触发灶显著增加了AAR风险,AF触发灶CA失败也如此。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cff7/10920014/835855cb7133/circrep-6-37-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cff7/10920014/bef3e18a6430/circrep-6-37-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cff7/10920014/b596f76c366e/circrep-6-37-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cff7/10920014/835855cb7133/circrep-6-37-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cff7/10920014/bef3e18a6430/circrep-6-37-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cff7/10920014/b596f76c366e/circrep-6-37-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cff7/10920014/835855cb7133/circrep-6-37-g003.jpg

相似文献

1
Impact of Atrial Fibrillation Triggers on Long-Term Outcomes of a Second Catheter Ablation of Nonparoxysmal Atrial Fibrillation.房颤触发因素对非阵发性房颤第二次导管消融长期结局的影响
Circ Rep. 2024 Feb 3;6(3):37-45. doi: 10.1253/circrep.CR-23-0069. eCollection 2024 Mar 8.
2
Clinical impact of eliminating nonpulmonary vein triggers of atrial fibrillation and nonpulmonary vein premature atrial contractions at initial ablation for persistent atrial fibrillation.初始消融持续性心房颤动时消除非肺静脉触发的房颤和非肺静脉房性期前收缩的临床影响。
J Cardiovasc Electrophysiol. 2021 Feb;32(2):224-234. doi: 10.1111/jce.14830. Epub 2020 Dec 18.
3
Impact of Non-Pulmonary Vein Foci on the Outcome of the Second Session of Catheter Ablation for Paroxysmal Atrial Fibrillation.非肺静脉起源灶对阵发性心房颤动第二次导管消融术结局的影响
J Cardiovasc Electrophysiol. 2015 Jul;26(7):739-46. doi: 10.1111/jce.12681. Epub 2015 May 25.
4
Long-term efficacy and safety of adjunctive ethanol infusion into the vein of Marshall during catheter ablation for nonparoxysmal atrial fibrillation.Marshall 静脉酒精输注辅助导管消融治疗非阵发性心房颤动的长期疗效和安全性。
J Cardiovasc Electrophysiol. 2019 Aug;30(8):1215-1228. doi: 10.1111/jce.13969. Epub 2019 May 30.
5
Impact of Uncontrolled Hypertension on Atrial Fibrillation Ablation Outcome.未控制的高血压对心房颤动消融结果的影响。
JACC Clin Electrophysiol. 2015 Jun;1(3):164-173. doi: 10.1016/j.jacep.2015.04.002. Epub 2015 Apr 20.
6
Impact of diagnosis-to-ablation time on non-pulmonary vein triggers and ablation outcomes in persistent atrial fibrillation.诊断至消融时间对持续性心房颤动中非肺静脉触发因素和消融结果的影响。
J Cardiovasc Electrophysiol. 2021 May;32(5):1251-1258. doi: 10.1111/jce.15002. Epub 2021 Mar 24.
7
Lack of prognostic value of atrial arrhythmia inducibility and change in inducibility status after catheter ablation of atrial fibrillation.心房颤动导管消融后心房心律失常可诱导性及其变化缺乏预后价值。
Heart Rhythm. 2018 May;15(5):660-665. doi: 10.1016/j.hrthm.2017.10.023. Epub 2017 Oct 19.
8
One-year outcomes after pulmonary vein isolation plus posterior wall isolation and additional non-pulmonary vein trigger ablation for persistent atrial fibrillation with or without contact force sensing: a propensity score-matched comparison.持续性心房颤动行肺静脉隔离加后间隔隔离及额外非肺静脉触发灶消融时应用或不应用接触力感应导管的一年结果:倾向性评分匹配比较。
J Interv Card Electrophysiol. 2020 Dec;59(3):585-593. doi: 10.1007/s10840-019-00700-1. Epub 2020 Jan 6.
9
Presence of non-pulmonary vein foci in patients with atrial fibrillation undergoing standard ablation of pulmonary vein isolation: Clinical characteristics and long-term ablation outcome.接受肺静脉隔离标准消融的心房颤动患者中非肺静脉病灶的存在:临床特征和长期消融结果。
Int J Cardiol Heart Vasc. 2021 Jan 21;32:100717. doi: 10.1016/j.ijcha.2021.100717. eCollection 2021 Feb.
10
Incidence and location of focal atrial fibrillation triggers in patients undergoing repeat pulmonary vein isolation: implications for ablation strategies.接受重复肺静脉隔离术患者局灶性心房颤动触发灶的发生率及位置:对消融策略的影响
J Cardiovasc Electrophysiol. 2003 Jul;14(7):685-90. doi: 10.1046/j.1540-8167.2003.03013.x.

引用本文的文献

1
Reply to the Letter.对该信件的回复。
Intern Med. 2025 Jun 1;64(11):1782-1783. doi: 10.2169/internalmedicine.4615-24. Epub 2024 Nov 8.

本文引用的文献

1
Association of isoproterenol infusion during catheter ablation of atrial fibrillation with outcomes: insights from the UC San Diego AF Ablation Registry.异丙肾上腺素输注在心房颤动导管消融中的作用:来自加州大学圣地亚哥房颤消融登记处的研究结果。
J Interv Card Electrophysiol. 2023 Aug;66(5):1243-1252. doi: 10.1007/s10840-022-01448-x. Epub 2022 Dec 12.
2
Long-term outcome of adenosine-induced atrial fibrillation after atrial fibrillation ablation: A propensity score matching analysis.心房颤动消融术后腺苷诱发的心房颤动的长期转归:倾向评分匹配分析。
Pacing Clin Electrophysiol. 2022 Sep;45(9):1172-1179. doi: 10.1111/pace.14557. Epub 2022 Jul 12.
3
Optimal single procedure strategy of pulmonary vein isolation with cryoballoon or radiofrequency and non-pulmonary vein triggers ablation for non-paroxysmal atrial fibrillation.
冷冻球囊或射频消融肺静脉隔离联合非肺静脉触发灶消融治疗非阵发性心房颤动的最佳单次手术策略
Int J Cardiol Heart Vasc. 2022 Apr 4;40:101021. doi: 10.1016/j.ijcha.2022.101021. eCollection 2022 Jun.
4
Presence of non-pulmonary vein foci in patients with atrial fibrillation undergoing standard ablation of pulmonary vein isolation: Clinical characteristics and long-term ablation outcome.接受肺静脉隔离标准消融的心房颤动患者中非肺静脉病灶的存在:临床特征和长期消融结果。
Int J Cardiol Heart Vasc. 2021 Jan 21;32:100717. doi: 10.1016/j.ijcha.2021.100717. eCollection 2021 Feb.
5
Pulmonary vein isolation alone vs. more extensive ablation with defragmentation and linear ablation of persistent atrial fibrillation: the EARNEST-PVI trial.单纯肺静脉隔离与碎裂电位消融和线性消融治疗持续性心房颤动的比较:EARNEST-PVI 试验。
Europace. 2021 Apr 6;23(4):565-574. doi: 10.1093/europace/euaa293.
6
RADAR: A Multicenter Food and Drug Administration Investigational Device Exemption Clinical Trial of Persistent Atrial Fibrillation.RADAR 研究:多中心食品和药物管理局突破性医疗器械临床试验——持续性心房颤动。
Circ Arrhythm Electrophysiol. 2020 Jan;13(1):e007825. doi: 10.1161/CIRCEP.119.007825. Epub 2020 Jan 16.
7
Targeting Nonpulmonary Vein Sources in Persistent Atrial Fibrillation Identified by Noncontact Charge Density Mapping: UNCOVER AF Trial.非接触式电荷密度标测指导下持续性心房颤动的非肺静脉触发灶消融:UNCOVER AF 试验
Circ Arrhythm Electrophysiol. 2019 Jul;12(7):e007233. doi: 10.1161/CIRCEP.119.007233. Epub 2019 Jun 27.
8
Pulmonary vein isolation plus left atrial posterior wall isolation and additional nonpulmonary vein trigger ablation using high-dose isoproterenol for long-standing persistent atrial fibrillation.肺静脉隔离加左心房后壁隔离以及使用大剂量异丙肾上腺素进行额外的非肺静脉触发灶消融治疗长期持续性心房颤动。
J Arrhythm. 2019 Feb 18;35(2):215-222. doi: 10.1002/joa3.12168. eCollection 2019 Apr.
9
Not all rotors, effective ablation targets for nonparoxysmal atrial fibrillation, are included in areas suggested by conventional indirect indicators of atrial fibrillation drivers: ExTRa Mapping project.并非所有作为非阵发性心房颤动有效消融靶点的转子都包含在心房颤动驱动因素的传统间接指标所提示的区域内:ExTRa Mapping项目。
J Arrhythm. 2018 Mar 8;34(2):176-184. doi: 10.1002/joa3.12036. eCollection 2018 Apr.
10
Non-pulmonary vein mediated atrial fibrillation: A novel sub-phenotype.非肺静脉介导的心房颤动:一种新型亚表型。
PLoS One. 2017 Sep 7;12(9):e0184354. doi: 10.1371/journal.pone.0184354. eCollection 2017.